U.S. President, Joe Biden, has tested positive for coronavirus.
The news, which was first announced on Thursday by White House press secretary, Karine Jean-Pierre, comes after the POTUS’ recently concluded trip to the Middle East. Jean-Pierre also stated that his present symptoms are mild; and he has received two boosts despite being fully vaccinated.
Due to President Biden’s age, he is currently under a Paxloid treatment course which entails a standard for higher risk COVID patients likely to suffer adverse effects. This involves anyone above the age of fifty. The Press Secretary of the White House also confirmed that presidential duties will continue to be carried out by Biden whilst isolating in the grand capital home. Staff contacts and communications will be limited to phone calls and Zoom meetings.
Prior to his recent positive result, the U.S. President had tested negative to the virus on Tuesday, but suffered fatigue, runny rose and an occasional dry cough the following day. This is according to a letter from his physician, Dr. Kevin O’Connor.
Meanwhile, First Lady Jill Biden is expected to stay on full schedule in Michigan and Georgia, after testing negative to COVID-19 on Thursday in Detroit. This was revealed by her spokesman Michael LaRosa through a brief mail.
‘She will continue following CDC guidance with masking and distancing.’
79-year-old Joe Biden is the oldest president in the history of the United States, and will be fully monitored due to the added risks the virus poses to older patients. His recent care plan shows the receipt of a fourth Pfizer BioNTech COVID-19 vaccine dose since its authorization for patients over fifty years four months ago.
Recent compile shows that he also stayed away from public space—save a Massachusetts event, after returning from a five-day trip to the Middle East. His recent diagnosis adds to the increasing case of the virus spurred by BA.5 variant.
Vaccines, boosters and other antiviral treatments will continue to be administered throughout the country while higher risk patients will be monitored closely.